Performance History
| Key Stats | |
|---|---|
| Open | $104.53 |
| Prev. Close | $104.74 |
| EPS | 3.21 |
| Dividend | $2.12 |
| Next Earnings Date | Aug 13, 2024 |
| Dividend Yield % | 2.07% |
| Market Cap | $184.69B |
| PE Ratio | 32.70 |
| LOW | HIGH | |
|---|---|---|
| Day Range | 104.44 | 105.50 |
| 52 Week Range | 89.67 | 121.64 |
| Ratios | |
|---|---|
| P/B Ratio | 4.90 |
| Revenue | $40.10B |
| Operating M. % | 15.41% |
| Earnings | $5.70B |
| Earnings Growth % | -17.77% |
| EBITDA Margin % | 25.85% |
| ROE % | 14.76% |
| EPS | 3.21 |
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
All Score 55 / 100 is to help users identify stocks that trade at a low value relative to their fundamentals. Suitable for value investors such as Warren Buffet.
| ABT | MARKET | |
|---|---|---|
| Value | 32 | 38 |
| Quality | 54 | 40 |
| Ownership | 34 | 17 |
| Growth | 44 | 46 |
| Dividends | 39 | 37 |
Abbott Laboratories's Price growth average in the last 3 years of -3.95% is modest compared to market average of 7.74%. This indicates ABT could be a bad value stock.
Financial Forecast
AI Price Prediction
Analyst Ratings
Correlated Companies
About Abbott Laboratories (ABT)
- Sector
- Healthcare
- Industry
- Medical Devices
- CEO
- Mr. Robert B. Ford
- Headquarters
- North Chicago
- Employees
- 115000
- Exchange
- NYSE
Keep an eye on Abbott Laboratories
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
What is Abbott Laboratories's (ABT) price per share?
The current price per share for Abbott Laboratories (ABT) is $104.98. The stock has seen a price change of $0.24 recently, indicating a 0.23% change. This reflects the stock's recent market performance and investor sentiment.
What is the 52-week high and low for Abbott Laboratories (ABT)?
For Abbott Laboratories (ABT), the 52-week high is $121.64, which is 15.87% from the current price. The 52-week low is $89.67, the current price is 17.07% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
Is Abbott Laboratories (ABT) a growth stock?
Abbott Laboratories (ABT) has shown an average price growth of 0.41% over the past three years. It has received a score of 47 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Abbott Laboratories as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
What is Abbott Laboratories (ABT) stock price performance year to date (YTD)?
As of the latest data, Abbott Laboratories (ABT) has a year-to-date price change of -4.43%. Over the past month, the stock has experienced a price change of -3.79%. Over the last three months, the change has been -6.71%. Over the past six months, the figure is 9.59%. Looking at a longer horizon, the five-year price change stands at 39.05%.
Is Abbott Laboratories (ABT) a profitable company?
Abbott Laboratories (ABT) has a net income of $5.7B, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 55.18% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 15.41% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $40.11B, although specific revenue growth data is currently not available. The gross profit is $22.13B. Operating income is noted at $6.48B. Furthermore, the EBITDA is $10.44B.
What is the market capitalization of Abbott Laboratories (ABT)?
Abbott Laboratories (ABT) has a market capitalization of $184.7B. The average daily trading volume is 4.66M, indicating the stock's liquidity and investor engagement.
News
Microsoft Leads in Carbon Dioxide Removal (CDR) Credit Purchases, Acquiring 6.6M Tonnes, Surpassing All Other Buyers Combined
SoftBank’s Profitability Surges Amid AI Investment Boom
Revolut Hit 26 Million Downloads in 2023, 65% more than a Year Before
US Smartphone Sales to Grow by Only 3% by 2028, 7x Less than in the Chinese Market
Xiaomi and Samsung Smartphones Identified Among Top Radiation Emitters in 2024
Traders Pile Up Short Positions as Grayscale Abandons Ethereum Futures ETF Plan
Sign up for our newsletter
Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.